108
Views
28
CrossRef citations to date
0
Altmetric
Research Article

The role of cytokines in corneal immunopathology

&
Pages 9-24 | Published online: 08 Jul 2009

References

  • Balkwill FR, Burke E The cytokine network. Immunol Today 1989;10:299–304.
  • Pleyer U. Corneal immunology and transplantation. General aspects. In: Keizer RJW, Jager M, Kijlstra A, editors. Handbook of Ocular Immunology. Buren: Aeolus Press, 1998;73–94.
  • Torres P, De Vos AF, Van der Gaag R, Kijlstra A. Expression of the interleukin i receptor antagonist in the normal human cornea. Ocular Immunol Inflamm 1994;2:217–222.
  • Kennedy MC, Rosenbaum JT, Brown J, Planck SR, Huang X, Armstrong CA, Ansel JC. Novel production of interleukin-I receptor antagonist peptides in normal human cornea. J Clin Invest 1995;95:82–88.
  • Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-' and IL-1 alpha messenger RNA production in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci 1992;33: 1756–1765.
  • Wilson SE, Lloyd SA. EGF and its receptor, basic FGF, TGF beta-1 and IL-I alpha messenger RNA production in human corneal endothelial cells. Invest Ophthalmol Vis Sci 1991;32:2747–2756.
  • Shams NB, Sigel MM, Davis RM. Interferon-gamma, Staphylococcus aureus and lipopolysaccharides/silica enhance interleukin i beta production by human corneal cells. Reg Immunol 1989;2:136–148.
  • Sakamoto S, Inada K, Chiba K, Yoshida M, Tazawa Y. Production of IL-6 and IL-I alpha by human corneal epithelial cells. Acta Soc Ophthalmol Jpn 1991;95: 728–732.
  • Planck SR, Huang X, Robertson JE, Rosenbaum JT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci 1994;35:924–930.
  • Sakamoto S, Inada K. Human corneal epithelial, stromal and endothelial cells produce IL-6. Acta Soc Ophthalmol Jpn 1992;96:702–709.
  • Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin 6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 1995;36: 330–336.
  • Staats HF, Lausch RN. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol 1993;151:277–283.
  • Elner VM, Strieter RM, Pavilack MA, Elner SG, Reurick DG, Dauforth JM, Kunkel SL. Human corneal interleukin-8: IL-I and TNF-induced gene expression and secretion. Am J Pathol 1991;139: 977–988.
  • Cubitt CL, Tang Q, Monteiro CA, Lausch RN, Oakes JE. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 1993;34: 3199–3206.
  • Dana MR, Yamada J, Streilein JW. Topical interleukin i receptor antagonist promotes corneal transplant survival. Transplantation 1997;63:1501–1507.
  • Dana MR, Dai R, Zhu S, Yamada J, Streilein JW. Interleukin-I receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest Ophthalmol Vis Sci 1998;39:70–77.
  • Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-I secretion and migration of Langerhans cells into the central cornea. Reg Immunol 1989;2:83–90.
  • Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996;8:271–280.
  • Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997;100:817–824.
  • Pearlman E, Lass JH, Bardenstein DS, Kopf M, Hazlett FE Jr, Diaconu E, Kazura JW. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med 1995;182: 931–940.
  • Chakravarti B, Lagoo-Deenadayalan S, Parker JS, Whitfield DR, Lagoo A, Chakravarti DN. In vivo molecular analysis of cytokine in murine model of ocular onchocerciasis. Upregulation of IL-4 and IL-5 mRNAs and not IL-2 and IFN-gamma mRNAs in the cornea due to experimental interstitial keratitis. Immunol Lett 1996;54:59–64.
  • Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol 1995;154:4822–4829.
  • Torres PF, De Vos AF, Van der Gaag R, Martins B, Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res 1996;63:453–461.
  • Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in the immune privilege. Immunol Today 1997;18:240–244.
  • Ferguson TA. The molecular basis of anterior associated immune deviation (ACAID). Ocular Immunol Inflamm 1997;5:213–215.
  • Stuart PM, Griffith TS, Usui N, Pepose JS, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99: 396–402.
  • Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;37: 2485–2494.
  • Kruse FE, Volcker HE. Stem cells, wound healing, growth factors, and angiogenesis in the cornea. Curr Opin Ophthalmol 1997;8:46–54.
  • Klintworth GK. Postinflammatory neovascularization. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunology. St. Louis: Mosby, 1996;112–132.
  • Kock AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376: 517–519.
  • Girard MT, Matsubara M, Fini E. Transforming growth factor beta and interleukin I modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991;32: 2441–2454.
  • West-Mays JA, Strissel KJ, Sadow PM, Fini ME. Competence for collagenase expression by tissue fibroblasts requires activation on an interleukin-I alpha autocrine loop. Proc Natl Acad Sci USA 1995;92: 6768–6772.
  • BenEzra D, Hemo I, Maftzir G. In vivo angiogenic activity of interleukins. Arch Ophthalmol 1990;108:573–576.
  • Hemo I, BenEzra D, Maftzir G, Birkenfeld V. Angiogenesis and interleukins. Ocular circulation and neovascularization. Doc Ophthalmol Proc Ser 1987;50:505–509.
  • Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992258:1798-1801.
  • Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992;141: 1279–1284.
  • Leibovich SJ, Polverini PJ, Shepard HM, Wisemann DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-a. Nature 1987;329:630–632.
  • Rosenbaum JT, Howes EL, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-a. Am J Pathol 1988;133:47–53.
  • Sunderkotter C, Roth J, Sorg C. Immunohistochemical detection of bFGF and TNF-a in the course of inflammatory angiogenesis in the mouse cornea. Am J Pathol 1990;137:511–515.
  • Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-a in angiogenesis. Am J Pathol 1992;140: 539–544.
  • Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998;188: 1039–1046.
  • Peek R, Van Gelderen BE, Bruinenberg M, Kijlstra A. Molecular cloning of a new angiopoietin-like factor from the human cornea. Invest Ophthalmol Vis Sci 1998;39:1782–1788.
  • Springer TA. Traffic signals for lymphocyte recirculation and leucocyte emigration: the multistep paradigm. Cell 1994;76: 301–314.
  • Lee J, Cacalano G, Camerato T, Toy K, Moore M, Wood W. Chemokine binding and activities mediated by mouse IL-8 receptor. J Immunol 1995;155:2158–2164.
  • Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992;33:626–640.
  • Gamache DA, Dimitrijevich SD, Weimer LK, Lang LS, Spellman JM, Graff G, Yanni JM. Secretion of pro-inflammatory cytokines by human conjunctival epithelial cells. Ocular Immunol Inflamm 1997;5:117–128.
  • Cubitt CL, Lausch N, Oakes JE. Differential induction of GRO-a gene expression in human corneal epithelial cells and keratocytes exposed to proinflammatory cytokines. Invest Ophthalmol Vis Sci 1997;38:1149–1158.
  • Tran MT, Tellaetxe-Isusi M, Elner V, Strieter RM, Lausch RN, Oakes JE. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. 13-chemokines synthesis in corneal cells. Invest Ophthalmol Vis Sci 1996;37:987–996.
  • Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-I-infected cornea. Invest Ophthalmol Vis Sci 1998;39: 1854–1862.
  • Tumpey TM, Cheng H, Cook DN, Smithies 0, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-I alpha prevents the development of blinding herpes stromal keratitis. J Virol 1998;72:3705–3710.
  • Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 1995;163:61–79.
  • Van Setten GB, Schultz GS, Macauley S. Growth factors in human tear fluid and lacrimal glands. Adv Exp Med Biol 1994;350:315–319.
  • West-Mays JA, Sadow PM, Tobin TW, Strissel KJ, Cintron C, Fini ME. Repair phenotype in corneal fibroblasts is controlled by an interleukin-I autocrine feedback loop. Invest Ophthalmol Vis Sci 1997;38:1367–1379.
  • Chedid M, Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin i. J Biol Chem 1994;269:1o753-1o757.
  • Wilson SE, Walker JW, Chwang EL, He YG. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor 2, and the cells of the cornea. Invest Ophthalmol Vis Sci 1993;34:2544–2561.
  • Weng J, Mohan RR, Li Q, Wilson SE. IL-, upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-I beta expression in the cornea. Cornea 1997;16:465–471.
  • Ohashi Y, Motokura M, Kinoshita Y, Mano T, Watanabe H, Kinoshita S, Manabe R, Ohshiden K, Yanaihara C. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci 1989;3o: 1879–1882.
  • Van Setten GB, Viinikka L, Tervo T, Pesonen K, Tarkkanen A, Perheentupa J. Epidermal growth factor is a constant component of normal human tear fluid. Graefe's Arch Clin Exp Ophthalmol 1989;227:184–187.
  • Kovalchuck LV, Khoroshilova-Maslova IP, Gankovskaya LV, Krainova TA, Gundorova RA, Ilatovskaya LV, Marteushev AV, Tumanov AV. Natural complex of cytokines is a potent stimulant to posttraumatic regeneration in rabbit cornea. J Ocular Pharmacol Ther 1996;12:271–279.
  • Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. Accelerated healing of incisional wounds in rats induced by transforming growth factor-13. Science 1987;237:1333–1336.
  • Elias JA, Lentz V, Cummings PJ. Transforming growth factor-13 regulation of IL-6 production by unstimulated and IL-, stimulated human fibroblasts. J Immunol 1991;146: 3437–3443.
  • Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S. Transforming growth factor-beta-1, -beta-2 and -beta-3 mRNA expression in human cornea. Curr Eye Res 1995;14:235–241.
  • Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991;32:2201–2211.
  • Wilson SE, Li Q, Barry-Lane PA, Jester JV, Liang Q, Wordinger RJ. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci 1996;37:1582–1592.
  • Strissel KJ, Rinehart WB, Fini ME. Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells. Invest Ophthalmol Vis Sci 1997;38:546–552.
  • Cubitt CL, Lausch RN, Oakes JE. Differential regulation of granulocyte-macrophage colony stimulating factor gene expression in human corneal cells by pro-inflammatory cytokines. J Immunol 1994;153:232–240.
  • Rosenbaum JT, Planck ST, Huang XN, Rich L, Ansel JC. Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci 1995;36: 2151–2155.
  • Hendricks RL, Jonwicz M, Tumpey TM. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-I-infected mouse corneas. J Immunol 1992;148: 2522–2529.
  • Hendricks RL, Tumpey TM. Contribution of virus and immune factors to herpes simplex virus type I induced corneal pathology. Invest Ophthalmol Vis Sci '990;31: 1929-1939.
  • Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol 1989;63:769–775.
  • Metcalf JF, Hamilton DS, Reichert RW. Herpetic keratitis in athymic (nude) mice. Infect Immunol 1979;26:I 164–1171.
  • Tang Q, Chen W, Hendricks RL. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol 1997;158: 1275–1283.
  • Hendricks RL, Tumpey TM, Finnegan A. IFN-y and IL-2 are protective in the skin but pathologic in the corneas of HSV-I-infected mice. J Immunol 1992;149: 3023–3028.
  • Kernacki KA, Berk RS. Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J Ocular Pharmacol 1994;I0:281–288.
  • Sotozono C, He J, Matsumoto Y, Kita M, Imanishi J, Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997;16:670–676.
  • Planck SR, Rich LF, Ansel JC, Huang XN, Rosenbaum JT. Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea. Ocular Immunol Inflamm 1997;5:95–100.
  • Becker J, Saila S, Dohmen U, Redbrake C, Reim M. Explorative study of interleukin levels in the human cornea. Graefe's Arch Clin Exp Ophthalmol 1995;233:766–771.
  • Fabre EJ, Bureau J, Pouliquen Y, Lorans G. Binding sites for human interleukin i alpha and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res 1991;10:585–592.
  • Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:108—H5.
  • Dayer JM, De Rochemoteix B, Burrus B, et al. Human recombinant interleukin i stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645–651.
  • Kennedy M, Kim KH, Harten B, Brown J, Planck S, Meshul C, Edelhauser H, Rosenbaum JT, Armstrong CA, Ansel JC. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cell. Invest Ophthalmol Vis Sci 1997;38: 2483–2491.
  • Shams, Reddy CV, Watanabe K, et al. Increased IL-1 activity in the injured vitamin A-deficient cornea. Cornea 1994;13:156–166.
  • Jones DT, Monroy D, Atherton SS, Pflugfelder SC. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994;35:3493–3504.
  • Foster CS, Wu HK, Merchant A. Systemic serum soluble interleukin-2 receptor levels in corneal transplants recipients. Doc Ophthalmol 1993;83: 83–90.
  • Pleyer U, Milani JK, Ruckert D, Rieck P, Mondino BJ. Determinations of serum tumor necrosis factor alpha in corneal allografts. Ocular Immunol Inflamm 1997;5:149–155.
  • Boisjoly HM, Laplante C, Bernatchez SF, Salesse C, Giasson M, Joly M-C. Effect of EGF, IL-1 and their combination on in vivo corneal epithelial wound closure and cell chemotaxis. Exp Eye Res 1993;57: 293–300.
  • Dupont E, Wybran J, Tonssaint C. Glucocorticosteroids and organ transplantation. Transplantation 1984;37:331–335.
  • Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporine A. Background, immunology and pharmacology. Cornea 1990;9: 184–195.
  • Torres PF, De Vos AF, Martins B, Kijlstra A. Interleukin-io does not prolong corneal graft survival in a rat model of corneal transplantation. Ophthalmic Res 1999;31:297–303.
  • Rosenbaum JT. Cytokines: the good, the bad and the unknown. Invest Ophthalmol Vis Sci 1993;34: 2389–2390.
  • Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-1o. J Immunol 1997;159: 1945–1952.
  • Larkin DFP, Oral HB, Ring CJA, Lemoine NR, George AJT. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996;61:363–370.
  • Arancibia-Carcamo CV, Oral HB, Haskard DO, Larkin DF, George Lipoadenofection-mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection. Transplantation 1998;65:62–67.
  • Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 1998;9:575–585.
  • Bourne WM. Reduction of endothelial cell loss during phakic penetrating keratoplasty. Am J Ophthalmol 1980;89:787–790.
  • Bourne WM, Hodge DO, Nelson LR. Corneal endothelium five years after transplantation. Am J Ophthalmol 1994;78:185–196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.